A New Protocol for Venous Thromboembolism Prophylaxis in Bariatric Surgery
| Autor: | M. A. Tolga Muftuoglu, Mehmet Odabasi, Haci Hasan Abuoglu |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Adult
Male medicine.medical_specialty Adolescent Endocrinology Diabetes and Metabolism Bariatric Surgery 030209 endocrinology & metabolism Postoperative Hemorrhage Vte prophylaxis Perioperative Care Young Adult 03 medical and health sciences 0302 clinical medicine Clinical Protocols medicine Humans Blood Transfusion Mass index Intermittent Pneumatic Compression Devices Nutrition and Dietetics business.industry Mortality rate Anticoagulants Nadroparin Venous Thromboembolism Heparin Middle Aged Compression device Obesity Morbid Surgery Female Laparoscopy 030211 gastroenterology & hepatology Median body business Venous thromboembolism medicine.drug |
| Zdroj: | Obesity Surgery. 29:729-734 |
| ISSN: | 1708-0428 0960-8923 |
| Popis: | Morbidly obese patients are at high risk for developing venous thromboembolism (VTE). The aim of this study was to evaluate the effect of a new VTE prophylaxis protocol (low dosage, low-molecular-weight heparin [LMWH]) with a pneumatic compression device (PCD) in patients undergoing bariatric surgery. Between November 2015 and December 2017, 368 patients underwent surgery due to obesity. The patients received 0.2 ml of nadroparin (Fraxiparine, GlaxoSmithKline) 12 h before the operation. A PCD (Kendall SCD Compression System) was applied to the patient during the operation and left on the patient during the subsequent 24 h. Nadroparin 0.4 ml was started subcutaneously after the PCD was removed from the patient and the same dosage of nadroparin was given daily for 15 days following the bariatric operation. Ambulation within 2 h of surgery was encouraged and was performed frequently. A total of 368 patients underwent laparoscopic bariatric surgery. The median age was 34.1 years (range, 18–61), the median weight was 128 kg (range, 90–182), and the median body mass index (BMI) was 47.2 kg/m2 (range, 36–72). No thrombotic events were observed postoperatively or at the 1-, 3-, and 6-month follow-up visits. Four bleedings occurred requiring transfusions. None of these patients required a re-laparotomy for hemorrhage control. The mortality rate was 0% at 30 and 90 days and during the hospitalization. Low dosage LMWH with PCD is very effective for VTE prophylaxis in bariatric surgery. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink